Glucagon-Linked Trial on Diet, Training and Fat-Mass Loss Updated

On October 23, 2026, the clinical trial titled "Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance" was listed as active but not recruiting. The study, registered as NCT07113561, involves glucagon and is classified as phase not applicable. Its current status indicates that enrollment has closed and the trial is proceeding with participants already enrolled. No results have been posted for this trial as of this update. The trial focuses on examining high-protein dietary intake combined with resistance training in relation to maintaining fat-mass loss. Glucagon remains an approved compound, and its inclusion in this study reflects ongoing research interest in metabolic and body composition outcomes. No efficacy or safety conclusions can be drawn from the trial's status alone. Further updates will depend on future postings to the clinical trial registry, including any changes in recruitment status or published results. Readers interested in glucagon's broader clinical and regulatory background can consult the compound overview for additional context.